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Abstract
Exposure to ultraviolet radiation (UVr) contained in sunlight is a major cause of skin 
illness such as sunburn, aging and cancer. UVr triggers local effects on the skin, which 
involve local inflammation, tissue remodeling, regulatory cytokines release and migra-
tion of dendritic cells (DCs). However, these localized effects on the exposed area are not 
the only ones that take place after sun or UVr exposure. A less known effect of UVr is the 
modulation of systemic immunity, through the generation of specific regulatory cells. 
These cells are induced, at least in part, by skin-migrating tolerogenic DCs. Moreover, 
bone marrow cell precursors can also be biased to a tolerogenic or suppressor phenotype. 
The sunlight- or UVr-induced immune system modulation can cause skin disorders like 
skin cancer and cutaneous photosensitivity in Lupus, but it also may be useful to treat 
cutaneous pathologies such as psoriasis and vitiligo. Moreover, the systemic immuno-
suppressor effect of UVr exposure may also be useful to treat autoimmunity of internal 
organs. Finally, as an inducer of cutaneous inflammatory response, UV phototherapy 
may also be useful in the treatment of cutaneous infections. Overall, UVr has profound 
immunomodulatory capacity that can be beneficial or deleterious for human health.
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1. Introduction
Sunlight is essential for life on the Earth, since there will be no nourishment provision for all 
the earth life forms without it. In addition to its central role in the production of large mac-
romolecules (carbohydrates) from carbon dioxide by photosynthetic organisms, it also plays 
an important role in promoting an adequate life environment through heat generation: our 
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planet’s average temperature is around 15°C, comparing with 482°C in Venus and −63°C in 
Mars (the two nearest planets of our system). Unfortunately, global temperature is increasing 
during the last years due to global warming, a problem that exceeds the scope of this chapter. 
Sunlight is an electromagnetic field composed of radiations with different wavelengths, rang-
ing from X-rays to infrared radiation. Some of these radiations are absorbed in the space and 
in our atmosphere. Due to this absorption, sunlight spectrum that reaches the Earth’s surface 
is composed of ultraviolet (UV) radiation (280–400 nm), visible light (400–720 nm) and near 
infrared radiation (720–2500 nm). The UV-radiation at the Earth surface is subdivided into 
UVB (280–320 nm) and UVA (320–400 nm), which have different characteristics in their effects 
on biological systems.
But sunlight not only provides warmth and food to the planet but also to the human beings. The 
different radiations that constitute the sunlight have impacts on mammalian cells, particularly 
on skin cells, since these are the naturally exposed cells. These effects are multiple and include 
DNA damage [1], reactive oxygen species (ROS) production [2], mitochondrial alterations [3, 4], 
matrix metalloproteases expression [5] and complex immune system changes, which are dis-
cussed in detail in this chapter. Many of these effects are specifically mediated through UV 
radiation, but visible light and infrared radiation also mediate cellular alterations [6].
Human skin exposure to sunlight has a range of effects on health, both beneficial and detri-
mental and not only cutaneous but also systemic.
On the side of the beneficial effects, the bright side, it is very well known that sun exposure 
is required to provide adequate amounts of circulatory Vitamin D, since this vitamin level 
depends on a step of UVB-induced photoisomerization of 7-dehydrocholesterol to previtamin 
D3 [7]. Sunlight has also been used to treat skin diseases. In ancient India and Egypt, there was 
a treatment for vitiligo that consisted of the consumption of an herbs extract and a subsequent 
exposure to the Sun, a treatment that is used in our days known as photodynamic therapy or 
photochemotherapy [8]. In 1901, Niels Ryberg Finsen published his work in which he treated 
Lupus vulgaris, a cutaneous infection caused by Mycobacterium tuberculosis, using an artificial 
source of ultraviolet light, during the years where the antibiotics were still undiscovered [9]. 
For his investigations, Finsen was awarded with the Nobel Prize in 1903, and he still remains 
as the only dermatologist in winning this prize, more than a century later. It is not surprising 
that sunlight has been employed as a treatment of different diseases. In 1903, the first hospital 
specialized in heliotherapy opened its doors in Switzerland. In that hospital patients with 
tuberculosis and rickets were treated with a precise schedule of sunbathing during several 
weeks [10]. Moreover, during the First World War, heliotherapy was used to treat ulcers and 
wounds in the absence of antibiotics.
However, there is also a dark side of sunlight exposure. It is also very well known that sun-
light has the ability to promote skin cancer, both melanoma and non-melanoma ones [11]. 
This ability to induce malignant transformation of skin cells and their subsequent progres-
sion to form a tumor is based on its capacity to induce DNA damage and mutations to the 
exposed cells. This damage, described in 1958, consists of the formation of pyrimidine dimers, 
a covalent bond between adjacent DNA bases, being the thymidine dimers the most frequent 
lesions [1]. Even though mammalian cells have a specialized enzymatic machinery to detect 
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and correct DNA lesions, these mechanisms can be overwhelmed leading to DNA mutations. 
Damaged cells can arrest their growth in order to detect and correct DNA damage, being p53 a 
key regulator of the process. If the damage is too extensive to be repaired, apoptotic cell death 
is initiated, through the intrinsic pathway [12]. Besides nuclear damage, UV radiation also 
promotes mitochondrial alterations, leading to electron transport chain uncoupling, loosing 
of mitochondrial membrane polarization and increasing superoxide anion production [13, 14].
UV radiation effects on the biology of exposed cells are very well known, but it also has pro-
found effects on immune system that may affect the local and systemic immune responses. 
These effects are studied in the field of photoimmunology and are presented in this chapter.
2. Ultraviolet radiation effects on skin immune system
As it was mentioned, sunlight has an important impact on human health. A vast majority of 
the effects initiated by sunlight are triggered by UV radiation, being UVB the most relevant in 
terms of induction of DNA damage and detrimental effects on immune system.
The UV-induced immune system alterations can be divided into direct effects and indirect 
effects. The first ones are produced on the exposed organs (most likely the skin, but also 
the eyes) by specific responses of UV-exposed cells, which have the ability to produce sev-
eral molecular mediators and, in the case of dendritic cells, to migrate. The second ones 
are induced in distant organs, both primary and secondary lymphoid organs, by the skin-
produced molecules and migrating cells.
2.1. Direct effects on cutaneous immune system
The energy contained in the UV radiation can be transferred to different molecules within 
skin cells. This energy transference can modify the target molecules, such as DNA, trans-
urocanic acid (UCA) and L-tryptophan, leading to molecular changes and a downstream 
cascade of complex cellular responses.
Trans-UCA absorbs energy from UVB radiation and isomerizes to cis-UCA, which interacts 
with the serotonin receptor [15], activating gene transcription and promoting reactive oxygen 
species (ROS) production [16], which may act as intracellular second messengers activating 
different kinases such as Erk1/2 in UVB-exposed keratinocytes [17]. But not only ROS can acti-
vate cellular kinases. After UV exposure, many intracellular pathways are activated, includ-
ing NF-κB and MAPK ones, leading to the transcription of many inflammation-related genes 
[18, 19].
As keratinocytes are the most abundant cell type in epidermis, around 95% of total cells, 
they are the most frequent target of UV radiation. This is particularly important considering 
that UVB radiation only reaches the epidermis, and UVA is the only one which can penetrate 
deeper into the skin to reach the dermis. For these reasons, keratinocytes are central play-
ers in the establishment of the UV-induced inflammatory response. These cells are able to 
sense and react to different stimuli (including UV radiation) by producing pro-inflammatory 
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cytokines (TNF-α, IL-1 α and IL-1β, IL-6, IL-18, INF-γ), chemokines (IL-8, CCL-20), growth 
factors (GM-CSF, VEGF-α) and antimicrobial peptides (α and β-defensins, cathelicidin, S100 
proteins and ribonucleases). These molecules create an environment that promotes vasodi-
latation and an increase in vascular permeability, leading to edema formation and recruit-
ment of different immune cells, such as neutrophils, macrophages and lymphocytes to the 
exposed area, reinforcing the inflammatory response. But keratinocytes are not the only cell 
type directly affected by UV radiation. Langerhans cells (LCs), the specific dendritic cell sub-
type present in the epidermis, are also affected. It has been very well described that after UV 
exposure, the epidermis is depleted of LCs [20], but it has also been established that in vitro 
UV-exposed LCs promotes defective T cell activation due to UV-induced LCs apoptosis and 
co-stimulatory molecules alterations [21, 22].
Besides keratinocytes and LCs, dermal cells also play an important role in the UV-induced 
cutaneous inflammation. Dermal fibroblasts, mast cells, macrophages and dermal dendritic 
cells can be stimulated both directly by UV radiation (mainly UVA, since UVB does not reach 
the dermis) and indirectly by epidermal produced soluble mediators [23–27]. As a conse-
quence of repetitive acute exposures to UV radiation, there is a degeneration of skin cells, 
a destruction of collagen fibers and blood vessels, which, in turn, leads to premature aging, 
photodermatoses and actinic keratosis. These alterations are consequence of the production 
of ROS by exposed keratinocytes and fibroblast and the increased production of metallopro-
teases, which finally ends in the extracellular matrix degradation.
Besides the abovementioned pro-inflammatory mediators, when the skin is exposed to UV 
radiation, keratinocytes and other immune cells, such as mast cells, neutrophils and mono-
cytes, also produce regulatory soluble mediators such as IL-10, IL-4, prostaglandin E2 (PGE2) and platelet-activating factor (PAF). PAF induces the expression of cyclooxygenase-2 (COX-2, 
the inducible form of the COX enzyme), which is necessary to produce PGE2. At the same time, cis-UCA induces keratinocyte’s production of neuropeptides that stimulates mast cells 
to release histamine, which, in turn, induces the production of PGE2 leading to a retro alimen-tation system. PGE2 induces the production of IL-4 by lymphocytes and monocytes, potentiat-ing the release of IL-10 by keratinocytes. In this way, all the described mechanisms converge 
in the production of IL-10.
UV-induced cutaneous inflammation can be controlled by specific regulation of the immune 
system. It has been recently described that both epidermal LCs and apoptotic keratinocytes 
are essential for the correct control of UV-induced cutaneous inflammation, through the 
phagocytosis of apoptotic keratinocytes by LCs [28].
2.2. Systemic effects on immune responses
As it was mentioned in the introduction, skin cancer development is one of the major health 
problems associated with UV exposure. This carcinogenic effect was first demonstrated in 
a mice model by Dr. George Marshall Finley in 1928 [29]. More than four decades later, 
Dr. Margaret Kripke observed that UV-induced skin carcinomas were highly immunogenic 
and were rejected once transplanted on naïve mice [30]. Dr. Kripke realized that there must 
had been something else than mutagenic effects on UV-radiation, and she proved that this 
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extra effect was a marked systemic immunosuppression that impeded the immune system 
to attack the tumor [31, 32]. Since Dr. Kripke pioneering work, photoimmunologists from 
all over the world have elucidated many mechanisms involved in UV-induced systemic 
immunosuppression [33].
One of the most employed models to study this specific suppression of immune responses is 
the contact hypersensitivity reaction (CHS) to different molecules (the most commonly used 
are oxazolone and dinitrofluorobenzene). The reaction consists of a first contact between the 
antigen and the skin, named sensitization, where specific T cell activation takes place in drain-
ing lymph nodes, and a second contact in the ear skin of sensitized animals, named challenge. 
After the challenge, a specific T cell-driven inflammatory response is established and can be 
measured as the increase in ear thickness. Using CHS reaction, it was demonstrated that sev-
eral immune cells are involved in the UV-induced immunosuppression:
• The DCs that migrate from the skin to lymph nodes to present antigens to T cells expose 
a tolerogenic phenotype after UV irradiation. This leads to the promotion of T cell differ-
entiation to a regulatory phenotype. The exact role of LCs in this process is controversial, 
since it was demonstrated that these cells are not essential to establish the UV-induced 
immunosuppression [27, 34], but it was also observed in other experiments that LCs are 
required to produce the phenomena [35]. These events were demonstrated applying the 
sensitizer onto the irradiated skin.
• During T cell activation by tolerogenic DCs in skin draining lymph nodes, a differentiation 
to regulatory T cells (Tregs) is produced [36]. These Tregs are antigen specific and may 
transfer the immunosuppressive estate when injected to naïve mice. Moreover, these Tregs 
can modulate new immature DCs to turn them into tolerogenic, reinforcing the suppres-
sion on the immune response [37].
• Skin mast cells can also migrate to the lymph nodes after irradiation. This migration is 
essential to establish the immunosuppression [38], and these mast cells are necessary for 
the generation of regulatory B cells (Bregs), which are other important regulators of the im-
mune response that are involved in the cutaneous response after UV exposure [39].
• Regulatory B cells, as well as Tregs, can modulate DCs’ induction of immunity [40], favor-
ing a vicious circle of specific immunosuppression that is set up after skin exposure to UV 
radiation.
The abovementioned cells produce their effects by sensing and releasing soluble mediators. A 
pivotal cytokine involved in this suppression is IL-10, since its blockade by specific antibod-
ies [41, 42] or using knock-out mice [43] leads to normal immune responses even after UV 
exposure. This cytokine is produced by many cells, described earlier in this chapter, such 
as keratinocytes [44], DCs [45], Tregs, mast cells [46] and Bregs. Vitamin D, whose synthesis 
in the skin is dependent on UV exposure, also plays an important role as a soluble media-
tor of UV-induced immunosuppression. This vitamin induces a tolerogenic phenotype on 
DCs in vitro [47] and can mimic the effect of the radiation in vivo [48]. Another important 
soluble mediator with systemic effects which is produced in the skin after UV exposure is 
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prostaglandin E2. This eicosanoid is a main product of cyclooxygenase-2 (COX-2), which is up-regulated in irradiated skin and whose drug-mediated blockade decreases the UV-induced 
immunosuppression [18]. Other soluble mediators have been implicated specifically in UVA-
induced suppression such as the alternative complement component factor B [49] and sero-
tonin [50]. Platelet-activating factor, TNF-α, IL-4 and histamine also play a role in that process.
Besides its effects on mature T and B cells during their activation in skin draining lymph 
nodes, UV radiation can also modulate the differentiation of immune cells in primary 
lymphoid organs. In particular, bone marrow cells are affected in UV-exposed animals. DCs 
(CD11c + cells) differentiated in vitro from the bone marrow of UV-exposed animals were less 
competent than the control cells (differentiated from non-exposed animals). The defective 
bone marrow precursor phenotype can be restored by treating the exposed animals with a 
COX-2 inhibitor, demonstrating the role of PGE2 in affecting bone marrow cells [51].
2.3. Other indirect effects on immune system
The effects of microbiota on immune system has been vastly described and is a topic of growing 
interest during the last years. Even though the most important efforts are directed to study and 
to explain the interaction of immune system with gut microbiota, this is not the only important 
microenvironment that may affect the human health. Skin microbiome is indeed an important 
stimulus for cutaneous immunity. It is composed of a complex group of microorganisms, includ-
ing bacteria, virus and fungus, which has their particular equilibrium. A disbalance in the com-
mensal microbial community may impact on skin health, as is the case of Staphylococcus aureus role 
in atopic dermatitis [52]. It is not the aim of this chapter to discuss in detail the role of skin micro-
biome in health and disease, but what is certain is that it can modulate the skin immune system.
Skin exposure to the Sun and UV radiation not only impact skin cells, but also may affect 
microorganisms living on the skin surface. The effect of the radiation on the microorganisms 
depends on the type of microbe, its life cycle (spores tend to be more resistant that other 
forms) and the location (microbes can penetrate deep into the skin appendages). However, 
UV radiation can definitely affect skin microbiota, leading to different interactions with both 
adaptive and innate immunity [53]. The exact role of UV radiation on skin microbiome and 
its effects on immune system need to be studied in detail during the next years, in order to 
elucidate their implications in skin diseases.
3. Role of UVradiation exposure and immune system modulation on 
skin diseases
As it was mentioned earlier in this chapter, the most important effect of UV radiation on 
human health is the induction of skin cancer and the establishment of an immunosuppressive 
environment which allows the growth of the tumors. However, skin cells malignant trans-
formation is not the only affection produced by UV radiation on the skin. Photosensitivity 
in Lupus erythematosus is also produced by UV exposure. Moreover, skin infections may be 
favored by skin UV irradiation. The mechanisms of these skin malignancies are discussed in 
the following sections.
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3.1. UV-induced immune effects implicated with skin cancer development
The skin exposure to sunlight, as well as to artificial sources of UV radiation, is the main etio-
logical factor in basal cell carcinoma, squamous cell carcinoma, cutaneous malignant mela-
noma, actinic keratosis and melanocytic nevi [11]. The mutagenic role of UV radiation was 
already mentioned, but it is important to mention the most common mutated genes in skin 
cancer. Even though the mutagenic effect is directed to DNA sites with adjacent pyrimidines, 
there are some target genes more frequently affected, as is the case of p53. The protein codi-
fied by this gene is crucial in the regulation of cell cycle, favoring cell arrest in order to allow 
enzymatic machinery, another important protective factor, to repair the UV-induced DNA 
damage. More than 60% of aggressive basal cell carcinoma was found to have mutations on 
p53 gene [54]. These mutations were also found in normal sun-exposed skin of skin cancer 
patients [55]. The importance of cellular DNA repair machinery can be seen in patients with 
xeroderma pigmentosum. These patients present an autosomal recessive deficiency of DNA 
repair enzymes, developing basal cell carcinoma and other skin cancers at a very young age 
[56]. These patients are highly susceptible to sunlight, and they need, in some cases, to com-
pletely avoid sun exposure, being known as “children of the moon” [57].
Besides cell biology affections produced by UV radiation, this carcinogen promotes systemic 
immunosuppression. The relevance of the immune system alterations in skin cancer can be 
weighted through different experimental data:
• As it was mentioned, IL-10 is a pivotal cytokine in UV-induced suppression, which is 
secreted by several cell types after skin irradiation. In IL-10 knock-out mice, it has been 
reported the absence of skin tumors after chronic UV irradiation, besides the mutagenic 
effect of the radiation [58]. Moreover, in human studies, it has been demonstrated that the 
presence of a polymorphism in the IL-10 promoter that leads to a deficient transcription of 
the gene is inversely correlated with the development of skin cancer in UV-exposed skin 
areas [59].
• Prostaglandin E2 is also a very important molecule implicated in the UV-induced skin 
carcinogenesis. The pharmacological blockade of its production, by oral or topical admin-
istration of the drugs, along chronic irradiation protocols in mice, lead to a decrease in the 
number and size of the tumors [60, 61]. The selective inhibition of the inducible isoform 
of the enzyme cyclooxygenase (COX-2) by drugs, like Celecoxib, as well as with nonselec-
tive drugs (COX-1 and COX-2 inhibitors), like indomethacin or naproxen, both show the 
same antitumoral effect [62]. However, even though the number of tumors is decreased by 
these treatments, there is still a high frequency of mice with at least one tumor. The role of 
COX-2 in UV-induced skin tumors is described in detail in [18], but it is important to men-
tion that plenty of natural compounds derived from plants are effective in decreasing the 
expression or the activity of this enzyme.
• The relevance of IL-12 to the immune response against UV-induced tumors was reported 
by Meeran et al. [63]. They observed that the animals which were deficient in this cytokine 
were more sensitive to the UV-induced carcinogenesis, developing a greater number of 
tumors and also generating them in a shorter period of chronic irradiation.
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But the modulation of the immune system to allow transformed cells to growth is not the 
only effect of UV radiation. It has been recently reported that UV promotes angiogenesis and 
metastasis of melanoma, once this tumor is developed [64]. Using a genetically engineered 
mice model, Bald et al. demonstrated that, once the tumor is established, the chronic exposure 
to UV radiation lead to the release of DAMPs (damage associated molecular patterns) from 
keratinocytes, promoting an TLR-4-dependent inflammatory response. This inflammation 
recruits neutrophils and promotes vascular activation, allowing melanoma cells to invade 
blood vessels and to migrate to distant organs, like the lungs.
3.2. Role of UV exposure on cutaneous photosensitivity in systemic lupus 
erythematosus patients
Lupus (word that means wolf in Latin) is a widely known autoimmune disease, since 
Hippocrates times [65]. Its name was due to the characteristic destructive injuries that resem-
ble the bites of the animal. One of SLE patients’ main symptoms is a cutaneous rush on the 
face, butterfly-shaped, due to skin exposure to the Sun.
The immune mechanism involved in this symptom is supposed to be mediated by specific 
autoantibodies directed against nuclear proteins, Ro/SS-A 52, Ro/SS-A 60 and La/SS-B [66]. 
During the apoptotic cell death of irradiated keratinocytes, the nuclear antigens are relocated 
to the cellular membrane and exposed to the immune system [67, 68]. This exposure of nuclear 
antigens is supposed to be involved in two different processes:
• The induction of the specific autoantibodies, which involves the recognition of the apop-
totic bodies, with the nuclear antigens exposed on their membranes, by specific B cells. 
This recognition promotes the production and release of the specific autoantibodies 
anti-Ro/SS-A and anti-La/SS-B, a common laboratory finding in these patients.
• Once the autoantibodies are produced, they can reach the irradiated skin, recognize the 
apoptotic cells that expose the antigens on their surface and lead to an attack to the apop-
totic bodies by complement factors. This can ultimately produce the lysis of apoptotic cells, 
releasing their cellular content to the extracellular space. The release of the cellular content 
produces a strong inflammatory reaction where, in a normal condition, there will be no 
inflammation.
However, this theory does not explain why patients with other pathologies who are also posi-
tive for anti-Ro/SS-A and anti-La/SS-B autoantibodies, such as Sjögren’s syndrome patients, 
do not show cutaneous photosensitivity. This controversy is still present in the bibliography 
[69], and the molecular mechanism underlying the butterfly-shaped rush is still unknown.
3.3. Other skin conditions
As skin exposure to UV radiation affects DCs function, T and B cell activation, macrophage 
phagocytic activity and other immune mechanisms, it is expected to find alterations in 
responses against pathogens, including virus, bacteria, parasites and fungus [70]. In different 
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infectious diseases in mice models, it has been described the alteration of T cell function by 
exposing the animals to UV light before or after the infectious challenge [71]. It has been 
recently published that different procedures of irradiation, which include a single high UV 
dose and repetitive low UV doses, differentially affect the evolution of a Staphylococcus aureus 
cutaneous infection [72]. However, in humans, this effect is more elusive. There are just a few 
infections, mainly viral infections that have been observed to be affected by exposure to UV 
radiation.
4. Immune system modulation by UV radiation as a therapy
Due to the profound effects that UV radiation promotes on exposed cells and on local and 
systemic immune system, the use of this radiation for human therapy is widely spread. 
Besides all the knowledge on the molecular effects of UV radiation described earlier, the 
first therapeutic use of this radiation was Finsen’s work, mentioned in the introduction of 
this chapter, where he treated Lupus vulgaris using a carbon arc lamp, more than a cen-
tury ago [73]. Currently, UV phototherapy is mainly employed in different dermatological 
disorders, including psoriasis, vitiligo, atopic dermatitis and cutaneous T cell lymphomas 
[74]. However, the usage of phototherapy has also been proposed to treat different systemic 
conditions like autoimmune diseases. Phototherapy procedures include exposure to broad-
band UVB (BB-UVB), narrow-band UVB (NB-UVB) and psoralen + UVA (PUVA), but the 
analysis of their differences exceeds the purpose of this chapter [75].
4.1. Phototherapy effects in psoriasis
Psoriasis is a chronic inflammatory skin disease. It is characterized by cutaneous lesions, 
produced by hyperproliferation of keratinocytes under the control of T cells. In the patho-
genesis of the disease, different inflammatory cytokines are involved, like TNF-α and 
IL-17. UVB phototherapy has been widely used for psoriasis treatment during decades, 
evolving from BB-UVB to NB-UVB. The role of phototherapy in these patients can be 
inferred from the abovementioned molecular mechanisms induced by UV radiation. 
Basically, it promotes several changes in the affected skin, including the direct effect on 
keratinocytes preventing their proliferation and indirect effects on immune system. The T 
cell activity is unbalanced by UV radiation, increasing IL-4 production that affects Th-17 
and Th-1 profiles, both implicated in the perpetuation of the inflammatory state in the 
patients. In this way, UV phototherapy produces a decrease in the production of IFNγ, 
TNFα, IL-17 and IL-22 and an increment in IL-10 secretion. Moreover, an augmented 
migration of Tregs to the irradiated psoriatic skin has been observed, which may also 
contribute to control this disease [76].
UVB phototherapy must be rationally employed, since the chronic exposure to this treatment 
may increase the risk of skin cancer development. Patients under this therapy may have to 
replace it by any other available therapy, such as topical and systemic drugs or blocking anti-
bodies, after a prolonged period of use.
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4.2. Phototherapy in vitiligo
Vitiligo is an autoimmune disease characterized by the absence of melanin in particular zones 
of the skin, which remains unpigmented. This lack of pigmentation is due to deficient activity 
of melanocytes, the epidermal cells with the ability and the enzymatic machinery to synthe-
size this pigment [77].
Phototherapy in vitiligo promotes two main cellular effects such as the activation of 
melanocytes and the promotion of Tregs. The first effect is directly related to the lack of 
pigmentation, and melanocytes are sensitive to UV radiation as a signal that induces mela-
nin synthesis. In this way, UV phototherapy directly promotes the melanin synthesis. The 
second effect is associated to the main topic of this chapter, the modulation of the immune 
system by UV radiation. The mechanisms are the same that have been discussed in this 
chapter, but the goal is to induce immunological tolerance once it has been lost [78, 79]. 
The exact antigens that trigger vitiligo are unknown, but the mechanisms that lead to sup-
pression of immunity after UV irradiation seem to be effective to counteract this cutaneous 
autoimmune disease.
4.3. Experimental phototherapy for cutaneous infections
As it was mentioned, UV irradiation may promote several changes in skin and systemic 
immune system. These changes are dependent on the dose and the periodicity of the expo-
sure, and include local inflammation, activation of innate immune response, generation of 
tolerogenic DCs and Tregs [80]. Many of these changes can positively impact on the progres-
sion of cutaneous infections produced by different types of pathogens.
The parasite from the genus Leishmania, an endemic pathogen in some South American, 
African and Asian countries, promotes characteristic cutaneous lesions on infected individu-
als. Using mice models, it has been demonstrated that the exposure of animals to low dose UVB 
radiation (exposures on 4 consecutive days) prior to the challenge with Leishmania amazonensis 
promastigotes protects the animals against the cutaneous lesions. Moreover, UV-exposed ani-
mals presented higher levels of serum IFN-γ and TNF-α, compared to nonirradiated control 
infected mice [81]. These results demonstrate that cutaneous leishmaniasis can be modulated 
by UV radiation. However, the exposure to the radiation was performed prior to the parasite 
challenge, and the results cannot be extrapolated to a treatment for infected individuals. It 
is worth to notice that there is a research vacancy on experimental phototherapy for cutane-
ous leishmaniasis, but there are a few reports that have demonstrated the effectiveness of 
this treatment in mice models, which received UV or sunlight irradiation prior to the infec-
tion as well as during the long-term observation of the lesions. In the works of Giannini and 
Hoseinipoor et al., it can be observed that irradiated animals can recover from the infection 
faster than nonirradiated control animals [82, 83].
As UV radiation, especially UVC, present a direct bactericidal effect, it was directly used 
for the treatment of a cutaneous infection caused by antibiotic-resistant bacteria. The case 
reported by Aleem et al. shows the use of an UVC germicidal lamp to treat a poly-microbial 
burn wound infection. The infection was caused by Staphylococcus aureus, Klebsiella pneumoniae 
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and Pseudomonas aeruginosa, and the antibiotic therapy was unsuccessful. The physicians 
decided then to use UVC phototherapy and, finally, the 9-year-old patient recovered from 
the infection [84]. The success obtained with this treatment may be due to a direct germicidal 
effect or by immune system modulation. More studies need to be performed to clarify this 
point and to allow the establishment of new treatments for cutaneous infections produced by 
antibiotic-resistant bacteria.
4.4. Experimental phototherapy for autoimmune diseases
As it was mentioned earlier, skin exposure to UV radiation leads to an important systemic 
immunosuppression. The influence of this tolerogenic effect on an internal organ autoim-
mune disease was deeply studied by Dr. Scott Byrne’s group using a mice model of multiple 
sclerosis (MS), the experimental autoimmune encephalitis (EAE). They showed that exposing 
the animals to UV radiation prior to the antigenic challenge, and also during the evolution of 
the disease, it was possible to decrease the severity of the EAE, including the demyelination 
process [85]. This effect was dependent on B cells, since the protection against the pathology 
can be obtained by transferring B cells from irradiated animals to naïve mice. Moreover, phar-
macological depletion of B cell abolished the UV-mediated protection against EAE.
Being aware of these effects on mice, it seems promising to treat MS patients using photo-
therapy. Dr. Prue Hart faced this challenge, and set a clinical trial to treat patients suffering 
clinically isolated syndrome, who have a high susceptibility to develop MS [86]. The results of 
this clinical trial may open a new era on the treatment of autoimmune diseases using cutane-
ous phototherapy.
4.5. Extracorporeal blood irradiation
Skin exposure to UV radiation is not the only therapeutic procedure that employs artificial 
sources of this radiation. There are two procedures based on the extraction of blood from the 
patients and its subsequent exposure to a source of UV radiation: extracorporeal photophere-
sis (ECP) and ultraviolet blood irradiation (UBI). These two procedures base their efficacy on 
the modulation of the immune system. However, while ECP promotes a downregulation of 
immune effector mechanisms, UBI produces the opposite effect.
ECP consists of blood extraction, buffy coat separation, its subsequent mixture with a sensi-
tizer (psoralens) and an exposure to a UVA source. The irradiated white blood cells are then 
reinfused to the patient. This procedure has shown to be not only effective but also safe, and 
it has mainly mild and transient side effects. It was first described to treat cutaneous T cell 
lymphoma and chronic graft versus host disease, but it can also be employed in different 
autoimmune pathologies such as scleroderma, multiple sclerosis, Type 1 diabetes mellitus, 
rheumatoid arthritis or Crohn’s disease [87]. Its mechanism of action is not completely under-
stood, but it has been shown that the PUVA treatment produces the apoptosis of exposed 
cells, which are phagocyted by DCs once they are reinfused. These DCs acquire a tolerogenic 
phenotype, promoting the generation of regulatory T cells that ultimately lead to the control 
of the pathologic T cells [88].
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On the other hand, UBI is an old and almost forgotten technique, whose use was extensive 
in the 1940s and 1950s. Similarly to ECP, it consists of blood extraction with citrate (around 
5–7% of total blood) and its subsequent irradiation using UVC or UVB radiation, without any 
cellular separation. It was employed to treat many infectious diseases such as septicemia, 
tuberculosis and pneumonia, and other pathologies like arthritis and asthma [89]. The exact 
mechanisms of action are not fully understood, but it is known that an activation of antigen 
presenting cells is produced during the procedure. Even though this treatment has almost 
been abandoned, it may be a therapeutic option against multi-resistant bacterial infections.
5. Conclusions
Skin exposure to sunlight, specifically to UV radiation, triggers very well-known mecha-
nisms that may ultimately promote a profound modulation of the immune system, including 
both innate and adaptive immunity. This modulation of the immunological response leads 
to a defective control of tumor cells and pathogens. Moreover, as it affects systemic immu-
nity, it can also alter the response to vaccines. On the other hand, the knowledge of these 
detrimental effects has led to multiple options to treat immune-based pathologies. In this 
way, the potentiality of cutaneous and systemic immunomodulation by different types of 
phototherapy is yet far to be completely explored.
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